![](/img/cover-not-exists.png)
O-113 Cisplatin plus gemcitabine with or without vinorelbine asneo-adjuvant therapy for radically treatable stage III Non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (Grupo Oncológico del Norte de España)
Esteban, E., Fernández, Y., Vieitez, J., Villanueva, N., De Sande, J., Fra, J., Muñiz, I., Palacio, I., Fernández, J., Lacave, A.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80247-8
Date:
July, 2005
File:
PDF, 142 KB
english, 2005